G4G

4,4'-{(3S,4S)-PYRROLIDINE-3,4-DIYLBIS[(BENZYLIMINO)SULFONYL]}DIBENZAMIDE

Created:	2007-05-16
Last modified:	2011-06-04

Find Related PDB Entry
3 entries where G4G is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	78
Chiral Atom Count	2
Bond Count	82
Aromatic Bond Count	24

2D diagram of G4G

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4,4'-{(3S,4S)-PYRROLIDINE-3,4-DIYLBIS[(BENZYLIMINO)SULFONYL]}DIBENZAMIDE
Systematic Name (OpenEye OEToolkits)	4-[[(3S,4S)-4-[(4-aminocarbonylphenyl)sulfonyl-(phenylmethyl)amino]pyrrolidin-3-yl]-(phenylmethyl)sulfamoyl]benzamide
Formula	C₃₂ H₃₃ N₅ O₆ S₂
Molecular Weight	647.764
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=S(=O)(N(C3C(N(Cc1ccccc1)S(=O)(=O)c2ccc(C(=O)N)cc2)CNC3)Cc4ccccc4)c5ccc(C(=O)N)cc5
SMILES	CACTVS	3.341	NC(=O)c1ccc(cc1)[S](=O)(=O)N(Cc2ccccc2)[CH]3CNC[CH]3N(Cc4ccccc4)[S](=O)(=O)c5ccc(cc5)C(N)=O
SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)CN(C2CNCC2N(Cc3ccccc3)S(=O)(=O)c4ccc(cc4)C(=O)N)S(=O)(=O)c5ccc(cc5)C(=O)N
Canonical SMILES	CACTVS	3.341	NC(=O)c1ccc(cc1)[S](=O)(=O)N(Cc2ccccc2)[C@H]3CNC[C@@H]3N(Cc4ccccc4)[S](=O)(=O)c5ccc(cc5)C(N)=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)CN([C@H]2CNC[C@@H]2N(Cc3ccccc3)S(=O)(=O)c4ccc(cc4)C(=O)N)S(=O)(=O)c5ccc(cc5)C(=O)N
InChI	InChI	1.03	InChI=1S/C32H33N5O6S2/c33-31(38)25-11-15-27(16-12-25)44(40,41)36(21-23-7-3-1-4-8-23)29-19-35-20-30(29)37(22-24-9-5-2-6-10-24)45(42,43)28-17-13-26(14-18-28)32(34)39/h1-18,29-30,35H,19-22H2,(H2,33,38)(H2,34,39)/t29-,30-/m0/s1
InChIKey	InChI	1.03	SSQKDDJMCKLBOH-KYJUHHDHSA-N

Related Resource References

Resource Name	Reference
PubChem	24764428
ChEMBL	CHEMBL1188505

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.